Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Biosimulation Market, by Product
1.4.2 Asia Pacific Biosimulation Market, by Pricing Model
1.4.3 Asia Pacific Biosimulation Market, by End Use
1.4.4 Asia Pacific Biosimulation Market, by Application
1.4.5 Asia Pacific Biosimulation Market, by Deployment Model
1.4.6 Asia Pacific Biosimulation Market, by Therapeutic Area
1.4.7 Asia Pacific Biosimulation Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis – Global
4.1 Market Share Analysis, 2023
4.2 Strategies Deployed in Biosimulation Market
4.3 Porter Five Forces Analysis
Chapter 5. Asia Pacific Biosimulation Market by Product
5.1 Asia Pacific Software Market by Country
5.2 Asia Pacific Biosimulation Market by Software Type
5.2.1 Asia Pacific Molecular Modeling & Simulation Software Market by Country
5.2.2 Asia Pacific Clinical Trial Design Software Market by Country
5.2.3 Asia Pacific PK/PD Modeling and Simulation Software Market by Country
5.2.4 Asia Pacific Pbpk Modeling and Simulation Software Market by Country
5.2.5 Asia Pacific Toxicity Prediction Software Market by Country
5.2.6 Asia Pacific Other Software Type Market by Country
5.3 Asia Pacific Services Market by Country
5.4 Asia Pacific Biosimulation Market by Services Type
5.4.1 Asia Pacific Contract Services Market by Country
5.4.2 Asia Pacific Consulting Market by Country
5.4.3 Asia Pacific Other Services Type Market by Country
Chapter 6. Asia Pacific Biosimulation Market by Pricing Model
6.1 Asia Pacific License-based Model Market by Country
6.2 Asia Pacific Subscription-based Model Market by Country
6.3 Asia Pacific Service-based Model Market by Country
6.4 Asia Pacific Pay Per Use Model Market by Country
Chapter 7. Asia Pacific Biosimulation Market by End Use
7.1 Asia Pacific Life Sciences Companies Market by Country
7.2 Asia Pacific Academic Research Institutions Market by Country
7.3 Asia Pacific Other End Use Market by Country
Chapter 8. Asia Pacific Biosimulation Market by Application
8.1 Asia Pacific Drug Discovery & Development Market by Country
8.2 Asia Pacific Disease Modeling Market by Country
8.3 Asia Pacific Other Application Market by Country
Chapter 9. Asia Pacific Biosimulation Market by Deployment Model
9.1 Asia Pacific Cloud-based Market by Country
9.2 Asia Pacific On-premises Market by Country
9.3 Asia Pacific Hybrid Model Market by Country
Chapter 10. Asia Pacific Biosimulation Market by Therapeutic Area
10.1 Asia Pacific Oncology Market by Country
10.2 Asia Pacific Cardiovascular Disease Market by Country
10.3 Asia Pacific Infectious Disease Market by Country
10.4 Asia Pacific Neurological Disorders Market by Country
10.5 Asia Pacific Other Therapeutic Area Market by Country
Chapter 11. Asia Pacific Biosimulation Market by Country
11.1 China Biosimulation Market
11.1.1 China Biosimulation Market by Product
11.1.1.1 China Biosimulation Market by Software Type
11.1.1.2 China Biosimulation Market by Services Type
11.1.2 China Biosimulation Market by Pricing Model
11.1.3 China Biosimulation Market by End Use
11.1.4 China Biosimulation Market by Application
11.1.5 China Biosimulation Market by Deployment Model
11.1.6 China Biosimulation Market by Therapeutic Area
11.2 Japan Biosimulation Market
11.2.1 Japan Biosimulation Market by Product
11.2.1.1 Japan Biosimulation Market by Software Type
11.2.1.2 Japan Biosimulation Market by Services Type
11.2.2 Japan Biosimulation Market by Pricing Model
11.2.3 Japan Biosimulation Market by End Use
11.2.4 Japan Biosimulation Market by Application
11.2.5 Japan Biosimulation Market by Deployment Model
11.2.6 Japan Biosimulation Market by Therapeutic Area
11.3 India Biosimulation Market
11.3.1 India Biosimulation Market by Product
11.3.1.1 India Biosimulation Market by Software Type
11.3.1.2 India Biosimulation Market by Services Type
11.3.2 India Biosimulation Market by Pricing Model
11.3.3 India Biosimulation Market by End Use
11.3.4 India Biosimulation Market by Application
11.3.5 India Biosimulation Market by Deployment Model
11.3.6 India Biosimulation Market by Therapeutic Area
11.4 South Korea Biosimulation Market
11.4.1 South Korea Biosimulation Market by Product
11.4.1.1 South Korea Biosimulation Market by Software Type
11.4.1.2 South Korea Biosimulation Market by Services Type
11.4.2 South Korea Biosimulation Market by Pricing Model
11.4.3 South Korea Biosimulation Market by End Use
11.4.4 South Korea Biosimulation Market by Application
11.4.5 South Korea Biosimulation Market by Deployment Model
11.4.6 South Korea Biosimulation Market by Therapeutic Area
11.5 Singapore Biosimulation Market
11.5.1 Singapore Biosimulation Market by Product
11.5.1.1 Singapore Biosimulation Market by Software Type
11.5.1.2 Singapore Biosimulation Market by Services Type
11.5.2 Singapore Biosimulation Market by Pricing Model
11.5.3 Singapore Biosimulation Market by End Use
11.5.4 Singapore Biosimulation Market by Application
11.5.5 Singapore Biosimulation Market by Deployment Model
11.5.6 Singapore Biosimulation Market by Therapeutic Area
11.6 Malaysia Biosimulation Market
11.6.1 Malaysia Biosimulation Market by Product
11.6.1.1 Malaysia Biosimulation Market by Software Type
11.6.1.2 Malaysia Biosimulation Market by Services Type
11.6.2 Malaysia Biosimulation Market by Pricing Model
11.6.3 Malaysia Biosimulation Market by End Use
11.6.4 Malaysia Biosimulation Market by Application
11.6.5 Malaysia Biosimulation Market by Deployment Model
11.6.6 Malaysia Biosimulation Market by Therapeutic Area
11.7 Rest of Asia Pacific Biosimulation Market
11.7.1 Rest of Asia Pacific Biosimulation Market by Product
11.7.1.1 Rest of Asia Pacific Biosimulation Market by Software Type
11.7.1.2 Rest of Asia Pacific Biosimulation Market by Services Type
11.7.2 Rest of Asia Pacific Biosimulation Market by Pricing Model
11.7.3 Rest of Asia Pacific Biosimulation Market by End Use
11.7.4 Rest of Asia Pacific Biosimulation Market by Application
11.7.5 Rest of Asia Pacific Biosimulation Market by Deployment Model
11.7.6 Rest of Asia Pacific Biosimulation Market by Therapeutic Area
Chapter 12. Company Profiles
12.1 Certara, Inc.
12.1.1 Company Overview
12.1.2 Financial Analysis
12.1.3 Regional Analysis
12.1.4 Research & Development Expenses
12.1.5 Recent strategies and developments:
12.1.5.1 Product Launches and Product Expansions:
12.1.5.2 Acquisition and Mergers:
12.1.6 SWOT Analysis
12.2 Dassault Systemes SE
12.2.1 Company Overview
12.2.2 Financial Analysis
12.2.3 Regional Analysis
12.2.4 Research & Development Expense
12.2.5 SWOT Analysis
12.3 Advanced Chemistry Development, Inc.
12.3.1 Company Overview
12.4 Genedata AG (Danaher Corporation)
12.4.1 Company Overview
12.4.2 Financial Analysis
12.4.3 Segmental and Regional Analysis
12.4.4 Research & Development Expense
12.4.5 Recent strategies and developments:
12.4.5.1 Partnerships, Collaborations, and Agreements:
12.5 Instem Group of Companies
12.5.1 Company Overview
12.6 Chemical Computing Group ULC
12.6.1 Company Overview
12.7 Simulations Plus, Inc.
12.7.1 Company Overview
12.7.2 Financial Analysis
12.7.3 Segmental and Regional Analysis
12.7.4 Research & Development Expenses
12.7.5 Recent strategies and developments:
12.7.5.1 Partnerships, Collaborations, and Agreements:
12.7.5.2 Product Launches and Product Expansions:
12.7.5.3 Acquisition and Mergers:
12.7.6 SWOT Analysis
12.8 Schrodinger, Inc.
12.8.1 Company Overview
12.8.2 Financial Analysis
12.8.3 Segmental and Regional Analysis
12.8.4 Research & Development Expenses
12.9 PPD, Inc. (Thermo Fisher Scientific, Inc.)
12.9.1 Company Overview
12.9.2 Financial Analysis
12.9.3 Segmental and Regional Analysis
12.9.4 Research & Development Expenses
12.10. Physiomics Plc
12.10.1 Company Overview
12.10.2 Financial Analysis
Unique Offerings 